Preston Robert Tisch Brain Tumor Center at Duke

06/10/2026

June is Aphasia Awareness Month.

Aphasia is a condition that affects how a person speaks, understands, reads, or writes, often when the brain's language centers are impacted. For brain tumor patients, it can be one of the most disorienting parts of a diagnosis.

But aphasia changes communication, not intelligence, not identity, not who that person is.

With patience, the right care team, and the right support, people with aphasia continue to thrive.

Share this post to join us in spreading awareness.

06/07/2026

Today is National Cancer Survivors Day.

To every patient navigating a brain tumor diagnosis, every survivor who has fought their way to this moment, and every family that has walked — and continues to walk — this road:

We see you. We honor you. You are not alone.

💙

06/05/2026

June is National Migraine & Headache Awareness Month.

Most headaches are not caused by a brain tumor, but your body is always communicating. Persistent, worsening, or new headache patterns, especially when accompanied by other neurological changes like vision shifts, nausea, or confusion, deserve attention.

If something feels different, trust it. Our team is here when you need answers.

Learn more by visiting https://tischbraintumorcenter.duke.edu/blog/headache-could-it-be-brain-tumor 🔗

06/02/2026

In 2026, the Preston Robert Tisch Brain Tumor Center at Duke celebrates its 89th anniversary as one of the first brain tumor programs in the country and among the oldest of its kind.

For nearly nine decades, the Center has remained committed to advancing research, expanding treatment options, and providing comprehensive care for patients and families affected by brain tumors.

05/26/2026

Brain tumor patients rely on continued research, innovation, and access to advanced care.

Your support helps fund critical research, expand clinical trials, and bring new treatment options to patients. Consider making a gift, sharing this post, or reposting to help raise awareness and support progress in brain tumor research.

https://tischbraintumorcenter.duke.edu/givetoday

05/22/2026

About 90,000 people are diagnosed with a brain tumor each year in the United States, underscoring the significant and ongoing impact of this disease.

At the Preston Robert Tisch Brain Tumor Center at Duke, our teams are working to advance research, expand clinical trials, and develop innovative therapies to improve outcomes for patients and families. Through continued investment and collaboration, we are driving progress toward more effective treatments and a cure.

05/21/2026

Brain metastases are significantly more common than primary brain tumors and are an increasingly important area of focus in cancer care. As treatments improve and patients live longer, the likelihood of cancer spreading to the brain has also increased.

Almost all cancers have the potential to spread to the brain or spine, with lung, breast, prostate, kidney, melanoma, ovarian, and thyroid cancers among the most common sources. This underscores the need for specialized, multidisciplinary care and continued research to better understand and treat metastatic disease.

At the Duke Center for Brain and Spine Metastasis, our teams are advancing research and expanding treatment approaches to improve outcomes for patients facing brain metastases.

05/20/2026

Brain tumors are the leading cause of cancer-related death in children, underscoring the urgent need for continued research and specialized care.

Learn more about our pediatric neuro-oncology program and ongoing efforts to improve outcomes for children and families: https://tischbraintumorcenter.duke.edu/pediatric-neuro-oncology-program

Discover expert care for children with brain tumors at Duke’s Pediatric Neuro-Oncology Program. Leading research, treatment & family support.

05/19/2026

May is National Cancer Research Month, a time to recognize the critical role research plays in advancing care and improving outcomes for patients.

At the Preston Robert Tisch Brain Tumor Center at Duke, research is central to our mission. Our teams are working to better understand brain tumor biology, develop more effective and targeted therapies, and expand access to clinical trials. These efforts are essential to improving patient outcomes and moving the field forward.

Continued investment in research is key to accelerating discoveries and bringing new treatment options to patients and families.

05/15/2026

Thank you to everyone who made Angels Among Us 2026 such a meaningful day for the brain tumor community.

This year, nearly 5,000 participants and 279 teams came together in support of the Preston Robert Tisch Brain Tumor Center at Duke, helping raise $2,880,388 to advance brain tumor research and patient care.

Angels Among Us continues to reflect the strength of this community and the shared commitment to improving outcomes for patients and families affected by brain tumors. The support generated through this event helps drive research initiatives, clinical care, supportive care programs, and future treatment advancements at Duke.

We are grateful to every participant, donor, volunteer, sponsor, patient, survivor, caregiver, and supporter who contributed to this year’s event.